HealthCap

From Wikipedia, the free encyclopedia

Page Module:Infobox/styles.css has no content.Page Template:Infobox company/styles.css has no content.

HealthCap
Company type
Private
ISINScript error: No such module "WikidataIB".
IndustryScript error: No such module "WikidataIB".
PredecessorScript error: No such module "WikidataIB".
IncorporatedScript error: No such module "WikidataIB".
FoundedScript error: No such module "WikidataIB".
FounderScript error: No such module "WikidataIB".
DefunctScript error: No such module "WikidataIB".
SuccessorScript error: No such module "WikidataIB".
HeadquartersStockholm, Sweden and Lausanne, Switzerland
RevenueScript error: No such module "WikidataIB".
Script error: No such module "WikidataIB".
Script error: No such module "WikidataIB".
Total assetsScript error: No such module "WikidataIB".
Number of employees
Script error: No such module "WikidataIB".
ParentScript error: No such module "WikidataIB".
Websitewww.healthcap.eu

Script error: No such module "Check for conflicting parameters".Script error: No such module "Check for deprecated parameters".

HealthCap is a specialized provider of venture capital within life sciences. HealthCap invests in innovative companies with focus on therapeutics.[1] As of 2023, HealthCap has invested in over 125 companies since inception and completed initial public offerings of more than 45 companies.[2] HealthCap has offices in Stockholm and Lausanne.

History

The firm was founded in 1996 by Björn Odlander[3] and Peder Fredrikson,[4] and the first fund was started the same year.[5] As of 2023, HealthCap has established eight funds and financed more than 125 companies, where more than 45 have been taken public on nine different markets. The most recent fund, HealthCap VIII, was established in 2019. HealthCap has approximately 25 employees out of which thirteen are partners. The team combines venture capital investing experience with competences and work experiences from small as well as large companies across the healthcare industry, spanning disciplines of scientific research, drug development, clinical practice, investment banking, and industry management.[citation needed] Lua error in package.lua at line 80: module 'Module:Sidebar/configuration' not found.

Investments

HealthCap has raised eight main funds. Investors in HealthCap funds include, among others, European Investment Fund, Skandia Life Insurance, the 4th and 6th Swedish National Pension Funds, The Kresge Foundation, Mayo Clinic, Northwestern University, University of Michigan, Vanderbilt University and Washington University. HealthCap has committed capital exceeding EUR 1 billion.[6][7]

HealthCap invests in companies developing disruptive technologies that hold the potential to change clinical practice. Over the years HealthCap has invested in more than 125 companies. The portfolio companies have developed more than 20 pharmaceutical products and over 40 med-tech products to the market.[8] Many of these products, such as Firazyr®, Xofigo®, Tracleer®, are breakthrough therapies addressing life-threatening diseases. Examples of technologies financed by HealthCap are:

References

  1. ^ Page Module:Citation/CS1/styles.css has no content."Portfolio companies". HealthCap.
  2. ^ Page Module:Citation/CS1/styles.css has no content."Our Story - HealthCap". HealthCap. Retrieved 2017-07-14.
  3. ^ Page Module:Citation/CS1/styles.css has no content."Björn Odlander". Bloomberg Businessweek.{{cite web}}: CS1 maint: deprecated archival service (link)
  4. ^ Page Module:Citation/CS1/styles.css has no content."Peder Fredrikson". Bloomberg Businessweek.{{cite web}}: CS1 maint: deprecated archival service (link)
  5. ^ Page Module:Citation/CS1/styles.css has no content.""Många bolag är utsvultna på kapital". Veckans Affärer".
  6. ^ Page Module:Citation/CS1/styles.css has no content."Company Overview of HealthCap". Bloomberg Businessweek. Archived from the original on June 5, 2011.
  7. ^ Page Module:Citation/CS1/styles.css has no content."Nordic HealthCap announces final close of its fourth biotech fund at $322m". The Alternative Assets Network. 30 November 2001.
  8. ^ Page Module:Citation/CS1/styles.css has no content."HealthCap website". HealthCap.
  9. ^ Page Module:Citation/CS1/styles.css has no content."Expert Insights: Johnson & Johnson's Actelion buy establishes a Clear Leader in the Pulmonary Arterial Hypertension Market". Clinical Trials Arena. 2017-08-03. Retrieved 2022-05-17.
  10. ^ Page Module:Citation/CS1/styles.css has no content."Algeta ASA Raises Euro 23 Million in Series A Round". CRM. Archived from the original on 2016-03-04. Retrieved 2012-12-14.
  11. ^ Page Module:Citation/CS1/styles.css has no content.""HealthCap ökar sitt ägande i Q-Med". Q-Med".
  12. ^ Page Module:Citation/CS1/styles.css has no content."Medtronic Buying CoreValve for $700 Million+". Thomson Reuters.{{cite web}}: CS1 maint: deprecated archival service (link)
  13. ^ [1] Script error: No such module "webarchive". "Wilson Therapeutics" Life Science Sweden. April 17, 2014.
  14. ^ Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky, ML (2007). "Wilson's disease". Lancet 369 (9559): 397-408.

Lua error in package.lua at line 80: module 'Module:Navbox/configuration' not found.